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Lactobacillus helveticus is one of the species of lactic acid bacteria (LAB) most
commonly used in the production of fermented milk beverages and some types of
hard cheese. The versatile nature of this bacterium is based on its highly efficient
proteolytic system consisting of cell-envelope proteinases (CEPs), transport system and
intracellular peptidases. Besides use of L. helveticus in cheese processing, the production
of fermented milk preparations with health promoting properties has become an important
industrial application. Studies have shown that fermented dairy products are able to
decrease blood pressure, stimulate the immune system, promote calcium absorption,
and exert an anti-virulent effect against pathogens. These beneficial effects are produced
by a variety of peptides released during the hydrolysis of milk proteins by the proteolytic
system of L. helveticus, which provides the bacterium with its nutritional requirements for
growth. In recent years, studies have focused on understanding the factors that affect the
kinetics of milk protein hydrolysis by specific strains and have concentrated on the effect
of pH, temperature, growth phase, and matrix composition on the bacterial enzymatic
system. This review focuses on the role of the proteolytic system of L. helveticus in
the production of bioactive compounds formed during fermentation of dairy products.
Taking advantage of the powerful proteolytic system of this bacterium opens up future
opportunities to search for novel food-derived compounds with potential health promoting
properties.
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INTRODUCTION
Lactobacillus helveticus is a homofermentative, thermophilic lactic
acid bacterium widely used in the manufacture of Swiss type and,
Italian aged cheeses, and fermented milk drinks (Gatti et al., 2004;
Vinderola et al., 2007a). L. helveticus has the ability to reduce bit-
terness and give characteristic flavor to cheese, which makes this
bacterium an important component of starter cultures for the
dairy industry. Consumer interest in functional food has moti-
vated researchers to focus on the bioactive compounds formed
during fermentation of dairy products by lactic acid bacteria
(LAB) such as L. helveticus (Matar et al., 2003; Vinderola et al.,
2007b; Rattanachaikunsopon and Phumkhachorn, 2010; Wakai
and Yamamoto, 2012). Milk proteins are considered to be the
most important source of bioactive peptides that can be released
through hydrolysis by proteolytic microorganisms such as L. hel-
vetius (Meisel and Bockelmann, 1999; Matar et al., 2001; LeBlanc
et al., 2002; Fitzgerald and Meisel, 2003; Kenny et al., 2003; de
Moreno de LeBlanc et al., 2005). During milk fermentation only
1–2% of milk proteins undergo proteolysis and the principal sub-
strate is casein but limited degradation of whey proteins may also
occur (Khalid et al., 1991; Szwajkowska et al., 2011). The effect of
this proteolysis is that fermented milks have a higher content of
peptides and free amino acids, especially valine, histidine, serine
and proline, than non-fermented milk (Matar et al., 2003). LAB
rely on their complex proteolytic system to obtain all the neces-
sary free amino acids required for growth in milk. L. helveticus
strains are among the most nutritionally fastidious LAB as they
present multiple amino acid auxothrophies (Hebert et al., 2002).
In order to assure its nutritional requirements when grown in
milk, L. helveticus counts on a potent proteolytic system capable
of producing short peptides and liberating amino acids from the
casein matrix. This explains why it has higher proteolytic activ-
ity than most other lactobacilli and why it hydrolyses more casein
in culture media than other species (Savijoki et al., 2006). The
proteolytic system of L. helveticus and the majority of LAB con-
sists of proteinases which initially cleave caseins to large peptides,
peptidases (intracellular), which further degrade these peptides to
small peptides and amino acids, and specific transport proteins
which transport amino acids and peptides across the cytoplasmic
membrane (Kenny et al., 2003).
PROTEOLYTIC SYSTEM
PROTEINASES
The main source of amino acids and peptides produced by LAB
are derived from caseins, the most abundant protein in milk
(Meisel and Bockelmann, 1999). The hydrolysis of caseins by LAB
is initiated by a cell-envelope proteinase (CEP) that degrades the
protein into oligopeptides. Moreover, gene deletion studies have
shown that LAB are not able to grow in milk in the absence of a
functional CEP (Mayo et al., 2010). This enzyme belongs to the
family of subtilisin and it is a serine protease. CEPs are anchored
to the cell wall via a mechanism involving the typical sortase A
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(SrtA) (Dandoy et al., 2011). Most of the LAB possess only one
CEP but L. helveticus has been reported to have at least two: PrtH
and PrtH2 (Gilbert et al., 1997). The CEPs of LAB are synthe-
sized as preproteins of∼2000 residues and are composed of seven
functional domains: S, PP, PR, A, B, H, and W (Fernandez-Espla
et al., 2000). PrtH1 and PrtH2 present in L. helveticus differ from
the CEPs of other LAB because they lack the anchor domain
(AN), which is located at the C-terminus of the CEP sequence.
Some authors consider that there are at least two other types
of CEP in L. helveticus, namely PrtH3 and PrtH4 (Yamamoto
et al., 1998; Savijoki et al., 2006; Broadbent et al., 2011; Sadat-
Mekmene et al., 2011a). In L. helveticus CNRZ32, two genes
encoding the CEPs, prtH, and prtH2 have been reported (Sadat-
Mekmene et al., 2011b). Two additional putative genes encoding
CEPs have been recently detected in L. helveticus CNRZ32, prtH3,
and prtH4 (Jensen et al., 2009). In another study, an additional
gene, prtH5, was detected (Smeianov et al., 2007). The presence
of several genes encoding the proteolytic system of L. helveticus
could explain the high efficiency of its proteolytic system. From
the four identified genes, only prtH2 is common to all the charac-
terized strains of L. helveticus (Genay et al., 2009). A single gene
(prtH3) was found in strain DPC4571 (Broadbent et al., 2008),
the prtH2 gene is present in strains CNRZ2 and MI 2359, while
LHC2 seems to have just the prtH4 gene (Jensen et al., 2009).
L. helveticus CM4, which has a very strong hydrolytic system, has
been reported to have three CEP encoded genes: prtY, prtH2, and
prtM2 (Wakai and Yamamoto, 2012). A comprehensive study of
the proteolytic system of several strains of L. helveticus strains
using comparative genome hybridization microarray based on
L. helveticus CNZR 32 was published recently (Broadbent et al.,
2011). This study showed that there is a high intraspecific diver-
sity of genes encoding CEPs in the 51 strains of L. helveticus
analyzed. Twelve percent of the strains tested contained all four
CEP paralogs, 8% contained 3 paralogs, whereas 42% had genes
for just two CEPs. Among the strains tested the most abun-
dant paralog was prtH3, followed by prtH and prtH4 paralogs.
L. helveticus BGRA43 isolated from human feces has strong pro-
teolytic activity and is able to hydrolyze αs1-, β-, and κ-caseins
completely (Lozo et al., 2011). Analysis of the proteinase from
BGRA43 showed the only active gene was prtH. In L. helveticus as
in other LAB species, CEP activation requires a maturation pro-
teinase termed PrtM. In L. helveticus CNRZ32 two PrtMs (PrtM1
and PrtM2) have been identified (Savijoki et al., 2006). Further
studies (Genay et al., 2009; Broadbent et al., 2011; Zhao et al.,
2011) have reported that PrtM is required for activation of PrtH
and PrtM2 plays a role in activation of other CEP paralogs in
L. helveticus. The presence of the various CEPs in L. helveticus
strains that have been characterized is presented in Table 1.
PEPTIDE AND AMINO ACID TRANSPORT SYSTEM
The second stage of protein degradation is the transport of di-,
tri-, and oligo-peptides into the cell by different peptide transport
systems. One of the first publications on the peptide transport sys-
tem of L. helveticus concluded that Leu, Ile, Val, Thr, and Lys were
transported by a secondary transport system, whereas the amino
acids Asp, Glu, His, Arg, and Tyr seemed to be transported by
an ATP-driven system (Nakajima et al., 1998). After L. helveticus
strains DPC4571 (Callanan et al., 2008) and H10 (Zhao et al.,
2011) were sequenced and information regarding their transport
system became available, it was determined that strain DPC4571
possesses three peptide transport systems, the oligopeptide Opp
transport system and the di- and tri-peptide transport system,
Dpp and DtpT, respectively. Conversely, H10 has two peptide
transport systems, the Opp and dtpT systems. These results indi-
cate that the proteolytic system may differ between different
strains in L. helveticus.
PEPTIDASES
Peptidases are a very important part of the proteolytic system in
LAB since they are involved in the hydrolysis of peptides to release
essential amino acids (Christensen et al., 1999). Up until 2003
just 11 peptidases were known to be part of the proteolytic sys-
tem of L. helveticus: two proline-specific endopepeptidases, PepE
and PepO; a tripeptidase PepT; four aminopeptidases, PepX, PepI,
PepQ, and PepR; and four dipeptidases, PepD, PepV, PepC, and
PepN (Christensen et al., 1999; Savijoki and Palva, 2000; Kenny
et al., 2003; Pan and Tanokur, 2004). Recently it was reported
that strain CNRZ32 has seven oligoendopeptidases, three gen-
eral aminopeptidases, five proline-specific peptidases, eight di- or
tri-peptidases, and at least six other peptidases (Broadbent et al.,
2011).
The proteolytic system of L. helveticus CNRZ32 has been
widely studied (Khalid and Marth, 1990; Fernández et al., 1994;
Shao et al., 1997; Chen et al., 2003; Christensen and Steele, 2003;
Kilpi et al., 2007) due to its ability to reduce cheese bitterness
(Fernández et al., 1994) and to release peptides during milk fer-
mentation with angiotensin converting enzyme (ACE) inhibitory
activity (Kilpi et al., 2007). It is well known that peptides derived
from β-casein (f193–202) and α−s1 (f1–9) have been implicated
in the development of bitterness in cheese (Christensen et al.,
2003). For this reason, research has focused on studying the L. hel-
veticus endopeptidases that are responsible for the hydrolysis of
these caseins (Chen et al., 2003; Christensen et al., 2003). The
endopeptidase PepO2 plays a pivotal role in the ability of L. hel-
veticus CNRZ32 to reduce bitterness because of its specificity for
bonds containing proline. The peptidase PepDA was not neces-
sary for the liberation of essential amino acids since the deletion
of the gene pepDA had no effect on the growth of strain CNRZ32
(Dudley et al., 1996). Similarly, the dipeptidase with proline activ-
ity (PepR) has been found not to be a limiting enzyme for growth
of CNRZ32 (Shao et al., 1997). A recent study on the amino
peptidase activity of six strains of L. helveticus grown in milk or
MRS (de Man, Rogosa, and Sharpe) medium reported that the
mechanism of regulation depended on the specific peptidase and
possibly on the specific strain. Higher aminopeptidase activity
against almost all substrates used for the study was found after
growth in milk (Jensen and Ardo, 2010). The effect of amino-
peptidases PepN and PepX present in L. helveticus CNRZ32 on
the production of peptides with antihypertensive activity has
been also a subject of study. Milk fermented with peptidases-
negative mutants, induced higher production of ACE-inhibitory
activity compared with milk fermented with wild-type strains
(Kilpi et al., 2007). The importance of peptidases PepC, PepN,
and PepX for the growth of L. helveticus CNRZ32 was evident
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Table 1 | Cell envelope proteinases and origin of characterize L. helveticus strains.
L. helveticus strain Source and/or application CEP References
PrtH PrtH2
CNRZ32 Artisanal starter used in Comté, cheese starter used to reduce bitterness + + Pederson et al., 1999;
Dudley et al., 1996
CNRZ32JS Artisanal starter used in Comté + + Genay et al., 2009
CNRZ67 Artisanal lactic starter of Gruyère de Comté − + Genay et al., 2009
CNRZ240 Artisanal starter of Gruyère de Comté − + Genay et al., 2009
CNRZ241 Artisanal starter used in Comté + + Genay et al., 2009
CNRZ303 Artisanal starter used in Comté and Swiss cheese − + Deutsch et al., 2003; Zevaco
and Gripon, 1988
CNRZ328 Artisanal starter of Emmental; Prt− phenotype − + Hebert et al., 2002
CNRZ414 Cow milk Koumiss − + Genay et al., 2009
CNRZ450 Commercial starter of Emmental − + Genay et al., 2009
CNRZ498 Yogurt − + Genay et al., 2009
CNRZ762 Artisanal starter of Gruyère de Comté − + Genay et al., 2009
CNRZ891 Commercial starter − + Genay et al., 2009
CNRZ1080 Not determined − + Genay et al., 2009
CNRZ1095 Not determined − + Genay et al., 2009
CNRZ1111 Commercial starter − + Genay et al., 2009
CNRZ1317 Commercial starter used in Tallegio − + Genay et al., 2009
ISLC5 Artisanal lactic starter of Grana Padano − + Valence and Lortal, 1995
CP615 Not determined − + Genay et al., 2009
CP790 Starter for cultured milk products − + Yamamoto et al., 1993
CP53 − + Ono et al., 1997
CIP 103146T Artisanal starter used in Emmental − + Genay et al., 2009
CRL1062 Argentinean hard cheese − + Hebert et al., 1999;
Christiansen et al., 2007
CRL581 Argentinean cheese − + Hebert et al., 1997
ROSELL 5088 Not determined + + Genay et al., 2009
ROSELL 5089 Not determined + + Genay et al., 2009
DPC4571 Swiss cheese whey − + Slattery et al., 2010
ITG LH1 Whey + + Deutsch et al., 2000
ITG LH2 Aminopeptidase-deficient mutant strain derived from ITG LH1 − + Blanc et al., 2003
ITG LH3 Aminopeptidase-deficient mutant strain derived from ITG LH1 + + Blanc et al., 2003
ITG LH77 Artisanal starter, commercial strain − + Deutsch et al., 2000
L89 Starter for production of Grana cheese − + Martin-Minervini et al., 1994
PR4 Isolated from Italian cheese − + Minervini et al., 2003; Di
Cagno et al., 2006
ZUC2 Grana Padano cheese − + Scolari et al., 2006
when a multi-peptidase deletion mutant (pepC−, pepN−, and
pepX−) was studied. The growth rate inhibition in milk exhibited
by the mutants was overcome by supplementation with amino
acids associated with the peptidase that was absent in each of the
mutants (Christensen et al., 2003).
The essential role that L. helveticus peptidases have in the
manufacture of Swiss cheese was confirmed when the prote-
olytic systems of selected LAB were compared (Deutsch et al.,
2000). Peptidases of the L. helveticus strains tested showed higher
proteolytic activity as reported previously (Valence et al., 1998,
2000) and the presence of one carboxypeptidase in all the strains
tested was confirmed. An endopeptidase with the ability to
hydrolyze peptides Val-Pro-Pro-Phe-Leu and Ile-Pro-Pro-Leu-
Thr to produce Val-Pro-Pro and Ile-Pro-Pro, respectively, was
isolated and characterized from L. helveticus CM4 (Ueno et al.,
2004). Based on the results, it was suggested that the enzyme is
a key player in the hydrolysis of the C-terminal during the pro-
duction of Val-Pro-Pro and Ile-Pro-Pro in fermented milk. The
highest aminopeptidase activity for all the strains was observed
for the substrates Arg-, and Lys-pNA.
BIOACTIVE PEPTIDES PRODUCED FROM HYDROLYSIS OF
MILK PROTEINS
Today, milk proteins are considered the most important source
of bioactive peptides and an increasing number of bioactive
peptides have been identified in milk protein hydrolysates and
fermented dairy products (Clare et al., 2003; Silva and Malcata,
2005; Korhonen and Pihlanto, 2006). Milk can be the source of
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peptides with different bioactivities with potential interaction and
synergism among them as well as with other non-peptide com-
ponents. Upon oral administration, bioactive peptides may affect
the major body systems. For this reason, the potential of distinct
dietary peptide sequences to promote human health by reducing
the risk of chronic diseases or boosting natural immune protec-
tion has aroused a great deal of scientific interest over the past
few years (Schanbacher et al., 1998). Bovine milk contains 32 g/L
of proteins, of which 80% are caseins and 20% are whey pro-
teins. Casein, in addition to being a very efficient calcium and
phosphate transport for the newborn, hides a series of bioactive
molecules in its sequences. The caseins are a family of phos-
phoproteins and they have been designated αs1-, αs2-, β-, and
κ-caseins, with αs1 being the major protein found in bovine milk.
So far, no specific physiological property has been proposed for
the whole casein system, whereas various peptides that are inac-
tive in the amino-acid sequence have been proven to possess
bioactivities (Pihlanto-Leppala et al., 1999; Florisa et al., 2003;
Kilara and Panyam, 2003). CEPs of L. helveticus are highly specific
since the sites of cleavage on the caseins differ from one strain to
another depending on the type of casein (α- or β-casein) (Zevaco
and Gripon, 1988; Jensen et al., 2009; Sadat-Mekmene et al.,
2011a). A study conducted on the proteolytic system of L. hel-
veticus Zuc2, reported the potential presence of two CEPs (Scolari
et al., 2006). The most loosely bound CEP was partially charac-
terized, which was able to hydrolyze primarily β-casein and to a
lesser extent κ- and αs1-casein. The CEP cleaved αs1-CN (f1–23)
in contrast with other CEPs from various L. helveticus strains.
The proteolytic system of fifteen strains of L. helveticus more
efficiently hydrolyzed β-casein than αs1-casein (Sadat-Mekmene
et al., 2011b). Moreover, among all the tested strains there were
no differences in the extent and time of hydrolysis of β-casein
in strains with one CEP or more. Different studies have agreed
that CEPs of L. helveticus can cleave αs1- or β-casein at different
sites not specifically related to one type of amino acid (Zevaco
and Gripon, 1988; Broadbent et al., 2011; Sadat-Mekmene et al.,
2011b). For instance, strains L. helveticus CNRZ 303 and CP790
hydrolyzed several bonds at the C-terminal of β-casein, while
strains CNRZ 32, CNRZ 303 and LHC2 hydrolyzed β-casein at
the N-terminal (Jensen et al., 2009). Some strains of L. helveti-
cus such as CP790 (Yamamoto et al., 1994), CP53 (Ono et al.,
1997), and PR4 (Di Cagno et al., 2006) are able to hydrolyze
both αs1- and β-casein. Two comprehensive studies have con-
cluded that the hydrolysis of αs1-casein by L. helveticus strains
predominantly occurs at the N-terminal (Jensen et al., 2009;
Sadat-Mekmene et al., 2011a). However, it is clear that most of
the characterized strains of L. helveticus are able to extensively
hydrolyze β-casein. The CEPs of L. helveticus are also able to
hydrolyze κ-casein and αs2-casein; although to a lesser extent than
for the other caseins (Ezzat et al., 1985; Yamamoto et al., 1998;
Scolari et al., 2006; Jensen et al., 2009; Sadat-Mekmene et al.,
2011a).
Whey proteins have a globular structure and are more water-
soluble than caseins. The principle fractions are β-lactoglobulin,
α-lactalbumin, bovine serum albumin (BSA), and immunoglob-
ulins (Ig). In the past, whey was considered a waste prod-
uct or a raw material for relatively low-value commodities.
However, in the last decade with the emergence of new separation
technologies, the potential of whey proteins as bioactive com-
pounds has been realized (Chatterton et al., 2006).
Production of bioactive peptides from enzymatic hydrolysis
of whey proteins has been reviewed (Pihlanto-Leppala, 2001;
Madureira et al., 2010). The opioid peptides, α-lactorphin and
β-lactorphin were released during in vitro proteolysis of whey
proteins and whey hydrolysates showed ACE-inhibitory activity
after proteolysis with digestive enzymes, and several active pep-
tides (Pihlanto-Leppala, 2001). To date, there are few publications
that have focused on the production of bioactive peptides released
during fermentation of whey with LAB. L. helveticus LH-2 was
able to hydrolyze α-lactalbumin and release novel bioactive pep-
tides with immunomodulatory properties (Tellez et al., 2010).
Whey protein-based media have been used as a fermentation
substrate for L. acidophilus La-5 and bioactive molecules pro-
duced during its growth are able to down-regulate genes involved
in encoding the Type 3 Secretion System of E. coli O157:H7
(Medellin-Pena et al., 2007; Medellin-Pena and Griffiths, 2009;
Zeinhom et al., 2012) and Salmonella (Bayoumi and Griffiths,
2012).
PHYSIOLOGICAL ROLE OF THE BIOACTIVE COMPOUNDS
GENERATED BY L. helveticus
Traditionally milk proteins have been used as a raw mate-
rial to obtain bioactive peptides because it is considered to be
safe and relatively inexpensive. The production of bioactives in
fermented milk and cheese has been widely studied (Leclerc
et al., 2002; Matar et al., 2003; Gómez-Ruiz et al., 2004a,b;
Fitzgerald and Murray, 2006; Jensen et al., 2009; López-Expósito
et al., 2012). Upon oral administration, these bioactive pep-
tides may have an impact on various functions in the human
body depending on their amino acid sequence (Korhonen and
Pihlanto, 2006). Various peptides with physiological functions,
such as immunostimulating peptides, antimicrobial peptides,
opioid peptides, mineral binding peptides and antihyperten-
sive peptides have been isolated from products fermented with
L. helveticus.
ANTIHYPERTENSIVE
Antihypertensive peptides have been extensively reviewed (Ono
et al., 1997; Yamamoto et al., 1998; Wakai and Yamamoto, 2012).
The ability of L. helveticus to produce antihypertensive pep-
tides has been attributed to the CEP (Ono et al., 1997; Wakai and
Yamamoto, 2012). To date, no relationship has been established
between the antihypertensive effect and proteinase specificity. A
number of researchers have concluded that the functional prop-
erties of L. helveticus depend on the specific strain (Slattery et al.,
2010). Thus, strains CM4, CNRZ32, and DPC4571 that are able
to hydrolyze milk proteins to produce antihypertensive peptides
differ slightly in terms of their CEP genes when compared with
strains that are incapable of producing them (Sadat-Mekmene
et al., 2011b; Wakai and Yamamoto, 2012).
IMMUNOMODULATORY ACTIVITY
Milk fermented with L. helveticus can enhance specific and non-
specific immunity (Laffineur et al., 1996; LeBlanc et al., 2004;
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Vinderola et al., 2007a,b; Tellez et al., 2010, 2011). Milk fermented
with L. helveticus R389 was able to induce immune response and
exert a protective effect against Salmonella Typhimurium and
E. coli O157 (LeBlanc et al., 2004; Vinderola et al., 2007b). The
positive effect on the mucosal and tumoral immunity was directly
related to the proteolytic system of L. helveticus R389, since milk
containing the non-proteolytic variant was not able to instigate
an immune response (Matar et al., 2001). Although L. helveti-
cus R389 is able to hydrolyze milk proteins to produce bioactive
peptides that have a beneficial effect on the immune system, not
much work has been done to characterize the components of the
proteolytic system that is responsible for generation of these pep-
tides, nor on the identification of the peptides responsible for
the immunomodulatory effect. In vitro experiments have shown
that milk fermented with L. helveticus LH-2 can enhance cellu-
lar immune responses (Ng and Griffiths, 2002; Tellez et al., 2010)
and have a protective effect against Salmonella infection in vivo
(Tellez et al., 2011). Four novel bioactive peptides derived from
β-casein and α-lactalbumin following fermentation of milk with
L. helveticus LH-2 were identified (Tellez et al., 2010). Three of the
peptides share a common amino acid sequence with β-casein with
variation at N- and C-terminals (f 148–154, f 145–160, and f 143–
154). Peptides identified have in their structure a high percentage
of proline and also contain residues of lysine and histidine.
The S-layer protein extract of L. helveticus R0052 has been
shown to ameliorate the pathogenesis of E coli O157:H7
(Sherman et al., 2005; Johnson-Henry et al., 2007). Epithelial
cells treated with S-layer protein extract prior to infection with E.
coliO157 maintained their cellular integrity and barrier function.
Beganovic et al. (2011) isolated and characterized the S-layer from
L. helveticusM92 and tested its functionality in vivo. The slpA gene
encoding the S-layer protein was sequenced and compared with
other probiotic bacteria. The purified S-layer protein enhanced
the immunomodulatory response in Salmonella-infected mice to
a greater extent than L. helveticus M92 cells after the S-layer
protein was removed.
The antimutagenic effect of milk fermented with L. helveticus
L89 was attributed to the proteolytic system of this strain, since
the non-proteolytic variant (Prt−) did not have the same effect
(Matar et al., 1997).
ANTI-CANCER
An in vivo study using a model of breast cancer in mice concluded
that milk fermented with L. helveticus R389 or L. helveticus L89
delayed tumor development (de Moreno de LeBlanc et al., 2005).
Modulation of cytokine production and apoptosis of tumor cells
were observed in mice fed with fermented milk, which were
related to the potent proteolytic ability of strains used in this
study especially R389. In the same study, milk fermented with
a proteolytic-deficient variant of L helveticus L89 did not exert
the same regulatory response observed in mice fed with milk
fermented with R389 or L89.
CALCIUM BINDING
Recently, several strains of L. helveticus were tested to evaluate
their calcium binding ability. Supernatant from milk fermented
with L. helveticus LA, a highly proteolytic strain, exerted a high
Ca-binding activity (Dimitrov, 2009). A peptide produced from
the hydrolysis of alpha casein with A1 responsible for this effect
was purified and sequenced.
L. helveticus 16H and LBK-16H have been reported to have a
positive effect on calciummetabolism, bone volume, bone forma-
tion and bone mineral density (Narva et al., 2004a,b,c, 2007). An
in vitro study (Narva et al., 2004b) on the effect of milk fermented
with L. helveticus LBK-16H and its isolated peptides [isoleucyl-
prolylproline (IPP) and valyl-prolyl-proline (VPP)] exerted an
anabolic effect on bone. Milk fermented with L. helveticus 16H
was also shown to increase bone mineral density and bone min-
eral content in growing rats (Narva et al., 2004a). The same strain
has been reported to produce some bioactive peptides in milk,
which exert a positive effect on calciummetabolism (Narva et al.,
2004c). To test the effect of milk fermented with L. helveticus LBK-
16H and synthetic peptide VPP, a study on ovariectomized rats
was conducted (Narva et al., 2007). Fermented milk was able to
prevent bone loss while VPP dissolved in water did not prevent
ovariectomy-induced bone loss. Perhaps the synergies between
different components produced during fermentation could be
responsible for the functionality of fermented milk.
Table 2 presents a summary of the L. helveticus strains that
have been reported to produce bioactive peptides from milk
proteins.
Table 2 | Bioactive peptides produced from hydrolysis of milk proteins
by L. helveticus strains.
Bioactivity Strain References
Antihypertensive CP790 Wakai and Yamamoto, 2012
CP611
CP615
JCM1006
JCM1004
CNRZ32 Kilpi et al., 2007
CM4 Ueno et al., 2004
R211 Leclerc et al., 2002
R389 Leclerc et al., 2002
LMG 11474 Vermeirssen et al., 2003
LBK-16H Seppo et al., 2003
Immunomodulatory 5089 Laffineur et al., 1996
389 Matar et al., 2001; LeBlanc
et al., 2004; Vinderola et al.,
2007a,b
LH-2 Ng and Griffiths, 2002; Tellez
et al., 2010, 2011
R0052 Sherman et al., 2005;
Johnson-Henry et al., 2007
M92 Beganovic et al., 2011
L89 Matar et al., 1997
L89 de Moreno de LeBlanc
et al., 2005
Calcium binding 16H Narva et al., 2004a,b,c, 2007
LBK-16H
A1 Dimitrov, 2009
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EFFECT OF THE GROWTHMEDIUM ON THE L. helveticus
PROTEOLYTIC SYSTEM
Even though there are a number of studies that have investi-
gated the proteolytic ability of LAB, little is known about the
effect of the growth media on their proteolytic system. It is
well known that when milk is used as a growth media for
LAB, their proteolytic system is activated (Wakai and Yamamoto,
2012). This is caused by the limited amount of amino acids
present in milk and the nutritional needs of LAB. One of the
few studies done on the modulation of CEPs by peptide supply
(Hebert et al., 2002), concluded that the proteinase activity of
the LAB strains used in this study was reduced in cells grown
in a peptide-rich medium, such as MRS. Inparticular, the activ-
ity of L. helveticus CRL 1177 showed a 100-fold reduction in
enzyme activity when cells were grown in MRS. Conversely, the
peptidase activity of the L. helveticus strains tested were not
affected when grown in a peptide-rich medium. These results
agreed with previous findings of this research group (Hebert
et al., 2000). Another study conducted on the effect of L. helveti-
cus R0052 to inhibit E coli O157:H7 attachment (Johnson-Henry
et al., 2007), tested the influence of different media on the
S-layer protein. The authors concluded that, even though there
was no differences in the structural formation of the S-layer,
the physiological differences between bacteria grow under dif-
ferent conditions are unknown. Smeianov et al. (2007) showed
that L. helveticus CNRZ 32 genes encoding CEPs, endopepti-
dases and oligopeptide transporters were upregulated when the
strain was grown in milk compared with the levels of expres-
sion in MRS medium. In another study (Jensen et al., 2009),
CEP activity of six L. helveticus strains on αs1- and β-casein in
MRS and milk was evaluated. The CEPs of the different strains
hydrolyzed intact αs1- and β-casein after growth in milk, but not
in MRS.
The cell extract of six L. helveticus strains were analyzed for
aminopeptidase activity (Jensen and Ardo, 2010). It was con-
cluded that the peptidase activities were generally higher in the
L. helveticus strains after growth in skim milk than in MRS, with
the exception of Pro-pNA, which was affected by the growth
medium in a strain dependent manner. Other studies on the pep-
tidase activity of DPC 4571 and M10 in different growth media
showed similar results (Kenny et al., 2003; Simova and Beshkova,
2007). The regulation of genes encoding peptidases of L. hel-
veticus CNRZ 32 have been studied by Smeianov et al. (2007),
who observed an up-regulation of the pepI gene during growth
in MRS, up-regulation of the genes pepN, pepX, and pepR dur-
ing growth in skim milk, and the same level of expression of
pepC was seen in skim milk and MRS. The impact of the growth
medium on proteinase activity was evident in a study conducted
on L. helveticus CRL581 (Hebert et al., 1997). Proteinase activ-
ity decreased in the presence of an available nitrogen source and
showed an increment of activity when the growth medium was
milk.
CONCLUSIONS
Traditionally L. helveticus has been considered to be a very impor-
tant bacterium for cheese manufacture because its ability to
improve cheese quality. In the last 20 years it has became even
more relevant due to its ability to produce bioactive compounds
during milk fermentation. The industrial importance of L. hel-
veticus depends on its effective proteolytic system, which seems to
be the most efficient between LAB, as well as the specificity of dif-
ferent strains. We have gained some knowledge of the proteolytic
system of this bacterium but there are still aspects that require
further study. For instance, little is known regarding the speci-
ficity of the CEP on caseins, the transport system of the peptides,
and the factors that can affect both the individual components of
the system and the proteolytic system as a whole. Variations in the
proteolytic system of different strains might not be a pivotal fac-
tor for growth of the L. helveticus but might have a big impact
on the production of bioactive peptides. With the genetic and
biochemical tools available it is possible to manipulate the prote-
olytic system, which can lead to production of bioactive peptides
of particular interest or alternatively enzymes isolated from suit-
able microorganisms can be used alone. Technological challenges
in cheese production can be overcome by gaining a deeper under-
standing of the kinetics of milk hydrolysis by L. helveticus. More
research is necessary to shed light on the different components
of the proteolytic system of L. helveticus and other LAB and their
role in the production of health promoting compounds frommilk
fermentation.
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